You just read:

Pressure BioSciences' PCT Platform a Key Workflow Component in Study to Discover Potential Biomarkers and Underlying Pathways in the Emergence and Progression of COPD-Associated Lung Cancer

News provided by

Pressure BioSciences, Inc.

Jul 15, 2015, 09:23 ET